Click here to access insights and external resources collected by Nelson Mullins on the first 100 days of the new presidential administration and Congress. These articles and fact sheets are non-partisan in nature and address the impact of each on various industries and client sectors.
Click here to access our extensive COVID-19 resources that address a wide variety of topics in general and by industry.
April 2, 2021
EPA Announces Important New Assumptions on Reviewing Chemical Use Under TSCAour team of patent attorneys, litigators, and technical specialists work with biotechnology start-ups and leading pharmaceutical companies to enhance strategic thinking and provide creative solutions.
Nelson Mullins’ Life Sciences team is known for developing and implementing effective IP strategies and building strong patent portfolios. These practices protect and facilitate commercialization of products for companies ranging from biotechnology start-ups to leading pharmaceutical companies.
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
Our attorneys, patent agents, and technical specialists include staff immunologists and molecular biologists who are graduates or postdoctoral fellows from top universities, including Brown, Cornell, Harvard, Stanford, MIT, Tufts, and McGill.
We have knowledge of life science and antibody discovery / development technologies including
Our attorneys, patent agents, and technical specialists include chemists who have doctoral and undergraduate degrees, as well as postdoctoral and industry experience in a variety of chemical arts, including synthetic organic, inorganic, and bioorganic chemistry, as well as chemical engineering and chemical processing.
We have worked with clients in many areas of chemistry patent prosecution and due diligence including
Our team of attorneys and senior patent agents includes immunologists with Ph.D. degrees from Harvard University and graduate and post-doctoral experience from top research universities, institutions, and companies. Because of our experience in the immunology area and our reasonable billing rates, we are able to complete projects efficiently and cost effectively. We work with clients to develop budgets and project goals.
We have worked with clients in many technical areas of immunology patent prosecution and due diligence including
We assess the costs and risks of patent litigation, and alternative resolutions, when our clients are involved in developing new technologies or engaged in due diligence. Our litigation risk assessments enable clients to make informed business decisions when contemplating whether to commence litigation, how to respond to cease and desist letters, and how to defend against lawsuits that have been filed against them.
Nelson Mullins’ Life Sciences team is known for developing and implementing effective IP strategies and building strong patent portfolios. These practices protect and facilitate commercialization of products for companies ranging from biotechnology start-ups to leading pharmaceutical companies.
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
Our attorneys, patent agents, and technical specialists include staff immunologists and molecular biologists who are graduates or postdoctoral fellows from top universities, including Brown, Cornell, Harvard, Stanford, MIT, Tufts, and McGill.
We have knowledge of life science and antibody discovery / development technologies including
Our attorneys, patent agents, and technical specialists include chemists who have doctoral and undergraduate degrees, as well as postdoctoral and industry experience in a variety of chemical arts, including synthetic organic, inorganic, and bioorganic chemistry, as well as chemical engineering and chemical processing.
We have worked with clients in many areas of chemistry patent prosecution and due diligence including
Our team of attorneys and senior patent agents includes immunologists with Ph.D. degrees from Harvard University and graduate and post-doctoral experience from top research universities, institutions, and companies. Because of our experience in the immunology area and our reasonable billing rates, we are able to complete projects efficiently and cost effectively. We work with clients to develop budgets and project goals.
We have worked with clients in many technical areas of immunology patent prosecution and due diligence including
We assess the costs and risks of patent litigation, and alternative resolutions, when our clients are involved in developing new technologies or engaged in due diligence. Our litigation risk assessments enable clients to make informed business decisions when contemplating whether to commence litigation, how to respond to cease and desist letters, and how to defend against lawsuits that have been filed against them.
We use cookies to improve functionality and performance of our website and to provide you with the best possible browsing experience. These cookies include those which are strictly necessary for website operation, as well as those which are used for functionality and performance purposes.
For more information on how our Sites use cookies, click here to view our Cookie Policy.